Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval.
作者信息
Hakariya H, Ozaki A, Mulinari S, Moriarty F, Tanimoto T
机构信息
Interfaculty Institute of Biochemistry, University of Tuebingen, Auf der Morgenstelle 15, Tuebingen 72076, Germany.
Institute for Pharmaceutical and Social Health Sciences, Kyoto, Japan.
出版信息
QJM. 2025 Jan 1;118(1):3-4. doi: 10.1093/qjmed/hcae115.
PMID:38867701
Abstract
摘要
Zotero 插件